Topiramate description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Topiramate

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

TOPIRAMATE DESCRIPTION



Topiramate



CLINICAL PHARMACOLOGY

Mechanism of Action


PHARMACODYNAMICS



PHARMACOKINETICS






Metabolism and Excretion


Pharmacokinetic Interactions
Drug Interactions



Special Populations

Renal Impairment
PRECAUTIONS: Adjustment of Dose in Renal FailureDOSAGE AND ADMINISTRATION

Hemodialysis
DOSAGE AND ADMINISTRATION

Hepatic Impairment


Age, Gender, and Race
Special Populations: Renal ImpairmentPRECAUTIONS: Adjustment of Dose in Renal FailureDOSAGE AND ADMINISTRATION


Pediatric Pharmacokinetics



CLINICAL STUDIES



Epilepsy

Monotherapy Controlled Trial



Topiramate

Adjunctive Therapy Controlled Trials in Adult Patients With Partial Onset Seizures





Adjunctive Therapy Controlled Trial in Pediatric Patients Ages 2 to 16 Years With Partial Onset Seizures




Adjunctive Therapy Controlled Trial in Patients With Primary Generalized Tonic-Clonic Seizures




Adjunctive Therapy Controlled Trial in Patients With Lennox-Gastaut Syndrome



Target Topiramate Dosage (mg/day)ProtocolStabilization DosePlaceboa2004006008001,000

Protocol Efficacy ResultsPlacebo2004006008001,000mg/kg/day*

INDICATIONS & USAGE

Monotherapy Epilepsy



Adjunctive Therapy Epilepsy


TOPIRAMATE CONTRAINDICATIONS



WARNINGS

Metabolic Acidosis








Acute Myopia and Secondary Angle Closure Glaucoma



Oligohidrosis and Hyperthermia




Withdrawal of AEDs


Cognitive/Neuropsychiatric Adverse Events

Adults


ADVERSE REACTIONS


Psychiatric/Behavioral Disturbances

Somnolence/Fatigue


Pediatric Patients


Sudden Unexplained Death in Epilepsy (SUDEP)


PRECAUTIONS

Hyperammonemia and Encephalopathy Associated with Concomitant Valproic Acid Use





Kidney Stones




Paresthesia

Adjustment of Dose in Renal Failure
DOSAGE AND ADMINISTRATION
Decreased Hepatic Function


INFORMATION FOR PATIENTS



PRECAUTIONS: Kidney Stones



LABORATORY TESTS

WARNINGS

DRUG INTERACTIONS


Antiepileptic Drugs




AED Co-administeredAED ConcentrationTopiramate ConcentrationPRECAUTIONS, Hyperammonemia and Encephalopathy Associated with Concomitant Valproic Acid Use
Other Drug Interactions
Digoxin:

CNS Depressants:

Oral Contraceptives:
Hydrochlorothiazide (HCTZ):
Pioglitazone:
Lithium:
Haloperidol:
Amitriptyline:

Sumatriptan:

Propranolol:
Dihydroergotamine:
Others:

DRUG & OR LABORATORY TEST INTERACTIONS



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY











LABOR & DELIVERY




NURSING MOTHERS



PEDIATRIC USE

WARNINGS

GERIATRIC USE

CLINICAL PHARMACOLOGYDOSAGE AND ADMINISTRATION
Race and Gender Effects


TOPIRAMATE ADVERSE REACTIONS



Monotherapy Epilepsy






Topiramate Dosage (mg/day)Body System/ Adverse Event50400(N=160)(N=159)

Topiramate Dosage (mg/day)bBody System/ Adverse Event50400(N=57)(N=57)
Adjunctive Therapy Epilepsy





Incidence in Epilepsy Controlled Clinical Trials Adjunctive TherapyPartial Onset Seizures, Primary Generalized Tonic-Clonic Seizures, and Lennox-Gastaut Syndrome



Other Adverse Events Observed During Double-Blind Adjunctive Therapy Epilepsy Trials


Topiramate Dosage (mg/day)Body System/ Adverse EventcPlacebo (N=291)200-400 ( N=183)600-1,000 (N=414)
Incidence in Study 119Add-On TherapyAdults with Partial Onset Seizures



Body System/Adverse EventcTopiramate Dosage (mg/day)Placebo (N=92)200 (N=171)

Topiramate Dosage (mg/day)Adverse EventPlacebo (N=216)200 (N=45)400 (N=68)600-1,000 (N=414)

Body System/Adverse EventPlacebo (N=101)Topiramate (N=98)
Other Adverse Events Observed During All Epilepsy Clinical Trials


























Monotherapy Epilepsy






Topiramate Dosage (mg/day)Body System/ Adverse Event50400(N=160)(N=159)

Topiramate Dosage (mg/day)bBody System/ Adverse Event50400(N=57)(N=57)
Adjunctive Therapy Epilepsy





Incidence in Epilepsy Controlled Clinical Trials Adjunctive TherapyPartial Onset Seizures, Primary Generalized Tonic-Clonic Seizures, and Lennox-Gastaut Syndrome



Other Adverse Events Observed During Double-Blind Adjunctive Therapy Epilepsy Trials


Topiramate Dosage (mg/day)Body System/ Adverse EventcPlacebo (N=291)200-400 ( N=183)600-1,000 (N=414)
Incidence in Study 119Add-On TherapyAdults with Partial Onset Seizures



Body System/Adverse EventcTopiramate Dosage (mg/day)Placebo (N=92)200 (N=171)

Topiramate Dosage (mg/day)Adverse EventPlacebo (N=216)200 (N=45)400 (N=68)600-1,000 (N=414)

Body System/Adverse EventPlacebo (N=101)Topiramate (N=98)
Other Adverse Events Observed During All Epilepsy Clinical Trials


Autonomic Nervous System Disorders:
Body as a Whole:
Cardiovascular Disorders, General: Infrequent:
Central & Peripheral Nervous System Disorders:
Gastrointestinal System Disorders:
Heart Rate and Rhythm Disorders:
Liver and Biliary System Disorders:
Metabolic and Nutritional Disorders:
Musculoskeletal System Disorders:
Neoplasms:
Platelet, Bleeding, and Clotting Disorders:
Psychiatric Disorders:
Red Blood Cell Disorders:
Reproductive Disorders, Male:
Skin and Appendages Disorders:

Urinary System Disorders:
Vascular (Extracardiac) Disorders:
Vision Disorders:
White Cell and Reticuloendothelial System Disorders:
Postmarketing and Other Experience


DRUG ABUSE AND DEPENDENCE



OVERDOSAGE


WARNINGS



DOSAGE & ADMINISTRATION

Epilepsy




Monotherapy Use


Adjunctive Therapy Use

Adults (17 Years of Age and Over) - Partial Seizures, Primary Generalized Tonic- Clonic Seizures, or Lennox-Gastaut Syndrome

CLINICAL STUDIES, Adjunctive Therapy Controlled Trials in Patients With Primary Generalized Tonic-Clonic Seizures


CLINICAL STUDIES, Adjunctive Therapy Controlled Trial in Patients With Primary Generalized Tonic-Clonic Seizures

Patients with Renal Impairment


Geriatric Patients (Ages 65 Years and Over)
DOSAGE AND ADMINISTRATION: Patients with Renal ImpairmentCLINICAL PHARMACOLOGY: Special Populations: Age, Gender, and Race




Patients with Hepatic Disease


HOW SUPPLIED
















STORAGE AND HANDLING



INFORMATION FOR PATIENTS


What do TOPIRAMATE Tablets look like?
TOPIRAMATE Tablets

Topiramate

Note: The pictures above show the shapes and lettering of TOPIRAMATE tablets. The wording describes the strength and colors of the medication. Before taking your medicine, it is important to compare the tablets you receive from your healthcare professional or pharmacist with these pictures to make sure you have received the correct medicine.

WHAT IS TOPIRAMATE?

  • ●     alone to treat seizures in patients 10 years and older
  • ●     with other medicines to treat seizures in adults and children over age 2
WHO SHOULD NOT TAKE TOPIRAMATE?
Do not take TOPIRAMATE if you are allergic to anything in it.

WHAT SHOULD I TELL MY HEALTHCARE PROFESSIONAL BEFORE TAKING TOPIRAMATE?
Tell your healthcare professional about all of your medical conditions, including if you:
  • ●     have kidney problems, especially kidney stones, or are getting kidney dialysis
  • ●     have a history of metabolic acidosis (blood and body fluid abnormality)
  • ●     have liver problems
  • ●     have osteoporosis (weak or brittle bones) and/or soft bones (osteomalacia) or decreased bone density (osteopenia)
  • ●     have lung or breathing problems
  • ●     have eye problems, especially glaucoma
  • ●     have diarrhea
  • ●     have a growth problem
  • ●     are on a diet high in fat called a ketogenic diet
  • ●     are having surgery
  • ●     are pregnant or planning to become pregnant. It is not known if TOPIRAMATE can harm your unborn baby.
  • ●     are breastfeeding. TOPIRAMATE may pass into your milk. Talk to your healthcare professional about the best way to feed your baby while taking TOPIRAMATE.
  • ●     suffer from depression, mood problems or suicidal thoughts or behavior
Tell your healthcare professional about all the medicines you take
  • ●     other medicines that impair or decrease your thinking, concentration, or muscle coordination (e.g. central nervous system depressant medicines).
  • ●     birth control pills. TOPIRAMATE may make your birth control pills less effective. Tell your healthcare professional if your menstrual bleeding changes while you are taking birth control pills and TOPIRAMATE.

HOW SHOULD I TAKE TOPIRAMATE?
  • ●     Take TOPIRAMATE exactly as prescribed. Your healthcare professional will usually start you on a low dose of TOPIRAMATE and slowly increase your dose until the best dose is found for you.
  • ●     TOPIRAMATE Tablets should be swallowed whole. Avoid, chewing the tablets as they may leave a bitter taste.
  • ●     Never store any medicine and food mixture for use at a later time.
  • ●     TOPIRAMATE can be taken before, during, or after a meal. Drink plenty of fluids during the day to prevent kidney stones while taking TOPIRAMATE.
  • ●     If you take too much TOPIRAMATE, call your healthcare professional or poison control center right away or go to an emergency room.
  • ●     If you miss a single dose of TOPIRAMATE, take it as soon as you can. However, if you are within 6 hours of taking your next scheduled dose, wait until then to take your usual dose of TOPIRAMATE, and skip the missed dose. Do not double your dose. If you have missed more than one dose, you should call your healthcare professional for advice.
  • ●     Do not stop taking TOPIRAMATE unless a healthcare professional tells you to stop taking TOPIRAMATE. Your healthcare professional will tell you how to slowly stop taking TOPIRAMATE.
WHAT SHOULD I AVOID WHILE TAKING TOPIRAMATE?
  • ●     If you are taking Topiramate or other antiepileptic drugs for epilepsy or seizures, you may need to avoid activities where loss of consciousness (passing out) could result in serious danger to yourself or those around you (including swimming, driving a car, climbing in high places, etc.). Talk to your doctor before engaging in such activities.
  • ●     Unless prescribed by your healthcare professional, you should avoid other medicines that also impair or decrease your thinking, concentration, or muscle coordination (e.g. central nervous system depressant medicines).
  • ●     You should avoid drinking alcohol while taking TOPIRAMATE. Alcohol with TOPIRAMATE can make side effects such as sleepiness and dizziness worse.
  • ●     Do not drive a car or operate heavy machinery until you know how TOPIRAMATE affects you. TOPIRAMATE can impair your thinking, motor skills, and/or vision.
WHAT ARE THE POSSIBLE SIDE EFFECTS OF TOPIRAMATE?
TOPIRAMATE may cause the following side effects which can be serious:

  •      metabolic acidosis.Metabolic acidosis is a condition that happens when there is too much acid in your blood. Metabolic acidosis can cause symptoms such as tiredness, loss of appetite, irregular heartbeat, and impaired consciousness.Call your healthcare professional right away if you get these symptoms with TOPIRAMATE.Your healthcare professional should do a blood test (measurement of serum bicarbonate) to monitor your bicarbonate level while you are taking TOPIRAMATE.
  •      eye problems.Serious eye problems include:
  • ●               a sudden decrease in vision (acute myopia) with or without eye pain and
  • ●               a blockage of fluid in the eye causing increased pressure in the eye (secondary angle closure glaucoma).
Call your healthcare professional right away if you have a loss in vision or get eye pain. These problems can lead to blindness if not treated right away.
  •      decreased sweating (oligohidrosis) and increased body temperature (fever).Patients, especially children, should be watched closely for signs of decreased sweating and fever (increased body temperature), especially in hot temperatures. Some patients may need hospital treatment for this condition.
  •      effects on thinking and alertness.TOPIRAMATE may affect thinking skills and cause confusion, problems with concentration, attention, memory, and/or speech. TOPIRAMATE may cause depression or mood problems, tiredness, and sleepiness. Call your healthcare professional right away if you experience any of these side effects.
  •      dizziness or loss of muscle coordinationin patients who take TOPIRAMATE alone or with other seizure medicines.
  •      high blood ammonia levels and effects on mental activities.High ammonia in the blood can affect your mental activities and decrease alertness, can make you feel tired or fatigued, or can cause vomiting. This has happened when TOPIRAMATE has been used with a medicine called valproic acid.
  •      kidney stones.Drink plenty of fluids when taking TOPIRAMATE to decrease your chances of getting kidney stones.
  •      tingling of the arms and legs(paresthesia) is a common side effect of TOPIRAMATE.



WHAT SHOULD I DO IF I GET PREGNANT WHILE TAKING TOPIRAMATE?

How Should I Store TOPIRAMATE?
  • ●     Store at 20to 25(6877
  •      Keep TOPIRAMATE and all medicines out of the reach of children.



What Are the Ingredients of TOPIRAMATE?
Active Ingredient:
Inactive Ingredients:
  • ●     Tablets - lactose monohydrate, microcrystalline cellulose, pre-gelatinized starch, lactose monohydrate, sodium starch glycolate, magnesium stearate, opadry white (titanium dioxide, hypromellose 3cp, hypromellose 6cp, PEG 400, polysorbate 80) for 25 mg tablets, opadry yellow (titanium dioxide, hypromellose 3cp, hypromellose 6cp, PEG 400, polysorbate 80, iron oxide yellow) for 50 mg tablets, opadry yellow, hypromellose 6cp titanium dioxide, PEG 400, iron oxide yellow, polysorbate 80, iron oxide red) for 100 mg tablets and), opadry pink (titanium dioxide, hypromellose 6cp, PEG 400, iron oxide red) for 200 mg tablets.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Topiramate

Topiramate

Topiramate

Topiramate TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-395(NDC:13668-033)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
TOPIRAMATE TOPIRAMATE 100 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
HYPROMELLOSES
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
polyethylene glycol 400
SODIUM STARCH GLYCOLATE TYPE A POTATO
talc
titanium dioxide
FERRIC OXIDE YELLOW

Product Characteristics

Color Size Imprint Code Shape
yellow 8 mm 1033;100 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-395-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA079153 2011-07-19


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.